Julia Haller

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.

Wills Eye Health System & Wills Eye Institute is a renowned ophthalmology hospital established in 1832 as the first hospital in the United States specializing in eye care. The hospital is located in Philadelphia, PA. Wills Eye is consistently ranked as one of America's top ophthalmology hospitals by U.S. News & World Report and has the most nationally ranked ophthalmologists in the country. It is also the #1 academic training for its residency program as voted by physicians in the nation. Wills Eye provides a full range of primary and subspecialty eye care services, including cataract, cornea, retina, emergency care, glaucoma, neuro-ophthalmology, ocular oncology, oculoplastics, pathology, pediatric ophthalmology and ocular genetics, and refractive surgery. The hospital also has a network of seven multi-specialty, ambulatory surgery centers throughout the tristate area.